Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials

Retrieved on: 2025-02-05 22:17:57

Tags for this article:

Click the tags to see associated articles and topics

Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials. View article details on hiswai:

Excerpt

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial ...

Article found on: medicine.washu.edu